Description

COVIDH TECHNOLOGIES LIMITED has fixed record date of October 24, 2025 for rights issue offering 25 equity shares at Rs.10/- each for every 1 equity share held.

Summary

COVIDH TECHNOLOGIES LIMITED (BSE Code: 534920) has announced a rights issue offering 25 equity shares of Rs.10/- each at par for every 1 equity share held. The record date has been fixed as October 24, 2025, with trading to commence on ex-rights basis from the same date under settlement number DR-742/2025-2026.

Key Points

  • Rights ratio: 25 new equity shares for every 1 existing equity share
  • Issue price: Rs.10/- per share at par
  • Company: COVIDH TECHNOLOGIES LIMITED (BSE Code: 534920)
  • Record date: October 24, 2025
  • Ex-rights date: October 24, 2025
  • Settlement number: DR-742/2025-2026
  • Segment: Dematerialised Securities – Rolling Settlement

Regulatory Changes

No regulatory changes announced in this circular.

Compliance Requirements

  • Trading members must ensure all transactions in equity shares of COVIDH TECHNOLOGIES LIMITED are executed on ex-rights basis from October 24, 2025
  • Trading members are required to take note of the record date and ex-rights trading provisions

Important Dates

  • October 17, 2025: Circular issue date
  • October 24, 2025: Record date for determining rights issue eligibility
  • October 24, 2025: Ex-rights trading commences (Settlement DR-742/2025-2026)

Impact Assessment

Market Impact: The 25:1 rights ratio represents substantial dilution for existing shareholders who do not participate. This aggressive rights offering may indicate capital raising requirements by the company.

Shareholder Impact: Existing shareholders will have the right to subscribe to 25 new shares for each share held, requiring significant capital commitment to maintain proportional ownership. Non-participation will result in substantial dilution.

Trading Impact: Stock will trade on ex-rights basis from October 24, 2025, with expected price adjustment to reflect the rights entitlement separation.

Impact Justification

Standard rights issue notification affecting existing shareholders with 25:1 ratio, significant dilution potential but routine corporate action